EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes

(2010) Isabel Fofana et al.   GASTROENTEROLOGY

Claudin Association with CD81 Defines Hepatitis C Virus Entry

(2010) Helen J. Harris et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

(2010) Samira Fafi-Kremer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor

(2010) N. Kamiya et al.   JOURNAL OF GENERAL VIROLOGY

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

(2010) Jiannong Li et al.   Nature Chemical Biology

Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2

(2009) D. Flores-Benitez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors

(2009) C. Frecha et al.   BLOOD

EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt

(2009) Hui Miao et al.   CANCER CELL

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations

(2009) Sophie E. Krieger et al.   HEPATOLOGY

Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice

(2009) Nobuhiko Hiraga et al.   JOURNAL OF HEPATOLOGY

Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells

(2009) C. J. Mee et al.   JOURNAL OF VIROLOGY

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

(2009) Christophe Hézode et al.   NEW ENGLAND JOURNAL OF MEDICINE

Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains

(2009) Marlène Dreux et al.   PLoS Pathogens

Host neutralizing responses and pathogenesis of hepatitis C virus infection

(2008) Mirjam B. Zeisel et al.   HEPATOLOGY

The epidermal growth factor receptor ligands at a glance

(2008) Marlon R. Schneider et al.   JOURNAL OF CELLULAR PHYSIOLOGY

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

(2008) J. Witteveldt et al.   JOURNAL OF GENERAL VIROLOGY

Treatment failure in hepatitis C: Mechanisms of non-response

(2008) Andrew W. Tai et al.   JOURNAL OF HEPATOLOGY

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

(2008) H. J. Harris et al.   JOURNAL OF VIROLOGY

Modeling oncogene addiction using RNA interference

(2008) S. M. Rothenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?

(2008) M. Lackmann et al.   Science Signaling